by Amy Berger | Aug 5, 2020 | News, Publications and Press
IITRI is proud to share the promising news of one of our partners, Moleculin! Our team here at IITRI was contracted to perform additional in vitro testing of their drug candidate (WP1122) for antiviral effects against SARS-CoV-2. We used growth medium that more...
by Amy Berger | Mar 19, 2020 | Blog, News
IITRI is now in custody of the a SARS-CoV-2 strain responsible for COVID-19. Our team is working on characterizing the strain for in vitro studies and in vivo modeling to test current vaccines and antivirals in addition to developing new treatments for this...
by Amy Berger | Mar 4, 2020 | Events
UPDATE Unfortunately, this year’s Society of Toxicology (SOT) meeting has been cancelled due to ongoing concerns over the spread of COVID 19. As much as our team was looking forward to speaking with everyone at the Tox Expo, we support this decision and look...
Recent Comments